Who is developing trodusquemine? A turbulent history of a promising compound
•
6 min read
Over the past two decades, the compound trodusquemine (MSI-1436) has been passed between multiple companies, each exploring its potential for different conditions from obesity to muscular dystrophy. The tumultuous history of who is developing trodusquemine highlights the high-stakes and often volatile nature of pharmacological research and development.
